Implementation of Precision Medicine in High-risk Prostate Cancer
Recruiting · NCT06687421 · Observational (researchers observe without assigning treatment) · Lead sponsor: Andreas Josefsson
View the official record on ClinicalTrials.gov →Interventions studied
Active monitoringAndrogen deprivation therapyHigh-risk treatment SOCRadical prostatectomyRadiotherapy
What this trial is about
This project's objective is to initiate a prospective non-interventional clinical study to perform full molecular characterization and subtyping of the primary tumor prostate cancer patients. It will identify, compare, and select biomarkers for treatment response in high-risk/metastatic prostate cancer.
Who can take part
Age range
18 Years and older
Sex
Male
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Men investigated for suspected prostate cancer
- Signed consent form
Exclusion criteria
- Difficulties understanding information about the study due to linguistic, cognitive or other reason
Where it is running
1 location listed.
- Urology, Umeå University Hospital, Region Västerbotten - Umeå, Sweden